Clinical Trials

330 enrolled 32 charts 2 FDA

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease

NCT00463580 2025-07-08

Infliximab

60 enrolled 15 charts

Bipolar Disorder, Depression, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant

NCT02638701 2025-07-08

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

Phase 1/2 Recruiting

8 enrolled

Aneurysm, Vasculitis, Stroke

NCT03011268 2025-05-31

BIOSTOP

Phase NA Completed

174 enrolled

Colitis, Ulcerative, Recurrence

NCT03765450 2025-05-16

PROTOS

Active not recruiting

18 enrolled

Colitis, Ulcerative

NCT06136546 2025-05-07

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Phase 2 Recruiting

100 enrolled

Depression, Depressive Disorder, Major, Inflammation, Cognitive Dysfunction

NCT01804166 2025-02-04

A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)

Phase 4 Enrolling by invitation

1 enrolled 1 chart

Lymphoid

Colitis, Ulcerative, Crohn Disease, Lymphoma, Inflammatory Bowel Diseases

NCT04646187 2025-01-06

FREE

148 enrolled

Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

NCT01793519 2024-02-28

STARA

Phase 4 Unknown

290 enrolled

Arthritis, Rheumatoid, Autoimmune Diseases

NCT04798287 2022-06-22

STAR-RA-Cancer

Other hematologic neoplasm

105,711 enrolled

Arthritis, Rheumatoid

NCT05379049 2022-05-18

TNF-alpha

Unknown

80 enrolled

Arthritis, Arthritis, Rheumatoid, Spondylitis, Ankylosing

NCT04082910 2022-04-13

Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells

Phase 1/2 Unknown

30 enrolled

Cytokine Release Syndrome, Hematologic Neoplasms

NCT02136069 2021-12-03

GARDENIA

397 enrolled 32 charts

Colitis, Ulcerative

NCT03452501 2021-02-23

Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients

157 enrolled

Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

NCT04115423 2020-09-10

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab

Unknown

9,508 enrolled

Arthritis, Rheumatoid, Infections

NCT00112749 2020-07-31

Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer

Phase 2 Terminated

7 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Fatigue

NCT02778789 2019-09-26

Re-Bone

DermatologicGenitourinaryThoracic

66 enrolled

Arthritis, Rheumatoid

NCT02763761 2018-10-09

An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo

Phase 2 Withdrawn

Carcinoma, Renal Cell, Lung Neoplasms, Melanoma

NCT02743390 2017-11-09

Effects of the TNF-alpha Inhibiton on Hemodynamic Parameters in Resistant Hypertension

10 enrolled

Hypertension, Inflammation

NCT02457585 2017-05-15

Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis

Phase 2 Unknown

11 enrolled

Takayasu Arteritis

NCT02126020 2017-04-07

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Phase 1/2 Withdrawn

Pemphigoid, Benign Mucous Membrane, Stevens-Johnson Syndrome, Syndrome

NCT00040885 2016-12-07

Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)

67 enrolled

Thoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Lung Neoplasms

NCT01295151 2016-11-02

SWITCH

DermatologicOther neoplasm

122 enrolled

Arthritis, Rheumatoid

NCT02878161 2016-08-25

Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"

Phase 4 Unknown

240 enrolled

Arthritis, Rheumatoid

NCT00897312 2016-04-25

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Terminated

7 enrolled

Hepatitis C, Melanoma, Precancerous Conditions

NCT00325078 2015-12-29

Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease

Phase 1/2 Terminated

40 enrolled 11 charts

Crohn Disease, Granulomatous Disease, Chronic, Inflammatory Bowel Diseases

NCT00724672 2015-06-01

A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)

Withdrawn

Arthritis, Rheumatoid

NCT00004941 2015-03-25

Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease

94 enrolled

Gastrointestinal

Crohn Disease, Gastrointestinal Diseases, Rare Diseases

NCT02376478 2015-03-03

On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection

Classical hematologyGastrointestinal

222 enrolled

Psoriasis, Inflammatory Bowel Diseases

NCT00060502 2011-05-17

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia

Phase 2 Completed

73 enrolled

Anemia, Anorexia, Cachexia, Pancreatic Neoplasms

NCT00228839 2009-06-30

GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease

Phase 1 Completed

Graft vs Host Disease

NCT00432406 2009-03-11

Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis